Skip to main content
Signal8

ROCAMBOLI STEPHEN

SEC insider (Form 3/4/5 filer). CIK 0001221451. Director at Esperion Therapeutics, Inc. (ESPR). 1 reported Form 4/5 transaction since Sep 2024; latest on May 29, 2025. Located in ANN ARBOR, MI.

Companies ROCAMBOLI STEPHEN has filed insider reports for

  • Esperion Therapeutics, Inc. (ESPR): Director
ROCAMBOLI STEPHEN profile photo

ROCAMBOLI STEPHEN

CIK: 0001221451

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Esperion Therapeutics, Inc. logo
ESPR

Esperion Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Esperion Therapeutics, Inc. logo
    ESPR

    Esperion Therapeutics, Inc.

    May 29, 2025
    Award
    Direct
    33K shares-

1-1 of 1